Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations

被引：22
|
作者：
Andersson, Karl-Erik
Olshansky, Brian
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA
[2] Univ Iowa Hosp, Iowa City, IA USA
来源：
BJU INTERNATIONAL | 2007年 / 100卷 / 05期
关键词：
heart rate; muscarinic receptors; antimuscarinics; overactive bladder; cardiac disease;
D O I：
10.1111/j.1464-410X.2007.07100.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1007 / 1014
页数：8
相关论文
共 50 条
  • [31] Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives
    Salvatore, S
    Soligo, M
    Proietti, F
    Citterio, S
    Artibani, W
    Milani, R
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 120 (02) : 129 - 133
  • [32] Economic Impact Associated with Patients with Overactive Bladder on Drug Treatment with Mirabegron or Antimuscarinics in Spain
    Nunez, Aurora Ortiz
    de Almeida, Rodrigo Martins
    Arrom, Laura Mateu
    Terres, Carlos Rubio
    Rodriguez, Dario Rubio
    Blazquez, Ana Maria Mora
    ARCHIVOS ESPANOLES DE UROLOGIA, 2023, 76 (01): : 98 - 106
  • [33] Hyperlipidemia as a risk factor for discontinuation of prescribed antimuscarinics among geriatric overactive bladder patients
    Chen, Yu-Chen
    Chen, Hao-Wei
    Juan, Yung-Shun
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2019, 11 (04) : 255 - 256
  • [34] Mirabegron versus Antimuscarinics in the Treatment of Overactive Bladder: The Final Answer?
    Marcelissen, Tom A. T.
    Van Koeveringe, Gommert A.
    EUROPEAN UROLOGY, 2018, 74 (03) : 334 - 335
  • [35] Clustering of patients with overactive bladder syndrome
    Gross, James
    Vetter, Joel M.
    Lai, H. Henry
    BMC UROLOGY, 2021, 21 (01)
  • [36] Clustering of patients with overactive bladder syndrome
    James Gross
    Joel M. Vetter
    H. Henry Lai
    BMC Urology, 21
  • [37] Prevalence of cardiovascular co-morbidities in patients treated with antimuscarinics for overactive bladder (OAB)
    Andersson, K.
    Kahler, K.
    U, Ebinger
    NEUROUROLOGY AND URODYNAMICS, 2007, 26 (05) : 653 - 654
  • [38] Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects
    Hsiao, Sheng-Mou
    Su, Ta-Chen
    Chen, Chi-Fiau
    Chang, Ting-Chen
    Lin, Ho-Hsiung
    MATURITAS, 2014, 79 (01) : 65 - 69
  • [39] Analysis of heart rate variability in female patients with overactive bladder - Editorial comment
    Chancellor, MB
    UROLOGY, 2005, 65 (06) : 1113 - 1113
  • [40] The effects of darifenacin and tolterodine on heart rate (HR) in patients with overactive bladder (OAB)
    Olshansky, B.
    Foote, J.
    Arguinzoniz, M.
    Lheritier, K.
    Quebe-Fehling, E.
    Steel, M.
    NEUROUROLOGY AND URODYNAMICS, 2006, 25 (06) : 656 - 657
12345